GlaxoSmithKline PLC Asset Turnover Over Time
| GSK Stock | USD 40.50 0.16 0.39% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out GlaxoSmithKline PLC Performance and GlaxoSmithKline PLC Correlation. GlaxoSmithKline |
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 0.58 | Earnings Share 3 | Revenue Per Share 14.97 | Quarterly Revenue Growth 0.092 |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Asset Turnover Analysis
Compare GlaxoSmithKline PLC ADR and related stocks such as PetIQ Inc, Emergent Biosolutions, and Neurocrine Biosciences Asset Turnover Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PETQ | 2.2276 | 2.2276 | 2.2276 | 2.2276 | 2.2276 | 2.2276 | 2.4611 | 1.8935 | 1.067 | 1.0546 | 1.011 | 1.1378 | 1.1253 | 1.2692 | 1.62 |
| EBS | 1.7822 | 0.4999 | 0.4996 | 0.4991 | 0.4762 | 0.501 | 0.5038 | 0.5241 | 0.3509 | 0.4748 | 0.5395 | 0.6058 | 0.354 | 0.5719 | 0.87 |
| NBIX | 0.2462 | 0.5595 | 0.2712 | 0.0189 | 0.0416 | 0.0416 | 0.0411 | 0.1977 | 0.4544 | 0.6034 | 0.6029 | 0.5469 | 0.6285 | 0.5804 | 0.61 |
| HLN | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2375 | 0.2898 | 0.2771 | 0.3119 | 0.3319 | 0.23 |
GlaxoSmithKline PLC ADR and related stocks such as PetIQ Inc, Emergent Biosolutions, and Neurocrine Biosciences Asset Turnover description
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.My Equities
My Current Equities and Potential Positions
| GlaxoSmithKline PLC ADR | GSK |
 | HealthcareFama & French Classification |
| Location | United Kingdom |
| Exchange | New York Stock Exchange |
USD 40.5
Check out GlaxoSmithKline PLC Performance and GlaxoSmithKline PLC Correlation. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets |
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.